Effexor XR: Sustained Relief for Major Depressive and Anxiety Disorders
| Product dosage: 150mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.74 | $52.23 (0%) | 🛒 Add to cart |
| 60 | $1.27 | $104.47 $76.34 (27%) | 🛒 Add to cart |
| 90 | $1.10 | $156.70 $99.44 (37%) | 🛒 Add to cart |
| 120 | $1.03 | $208.93 $123.55 (41%) | 🛒 Add to cart |
| 180 | $0.94 | $313.40 $169.76 (46%) | 🛒 Add to cart |
| 270 | $0.90 | $470.10 $242.08 (49%) | 🛒 Add to cart |
| 360 | $0.86
Best per pill | $626.80 $311.39 (50%) | 🛒 Add to cart |
| Product dosage: 75mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.57 | $47.21 (0%) | 🛒 Add to cart |
| 60 | $1.10 | $94.42 $66.30 (30%) | 🛒 Add to cart |
| 90 | $0.94 | $141.63 $84.38 (40%) | 🛒 Add to cart |
| 120 | $0.87 | $188.84 $104.47 (45%) | 🛒 Add to cart |
| 180 | $0.79 | $283.26 $141.63 (50%) | 🛒 Add to cart |
| 270 | $0.73 | $424.90 $195.87 (54%) | 🛒 Add to cart |
| 360 | $0.71
Best per pill | $566.53 $254.13 (55%) | 🛒 Add to cart |
Synonyms
| |||
Similar products
Effexor XR (venlafaxine hydrochloride) is an extended-release antidepressant belonging to the serotonin-norepinephrine reuptake inhibitor (SNRI) class, specifically formulated to manage major depressive disorder (MDD), generalized anxiety disorder (GAD), social anxiety disorder (SAD), and panic disorder (PD). Its unique mechanism of action modulates key neurotransmitters in the brain, offering a dual approach for patients who may not achieve adequate response with SSRIs alone. The extended-release formulation ensures stable plasma concentrations over 24 hours, supporting consistent symptom control and improved tolerability. It is available by prescription only and requires careful medical supervision throughout treatment.
Features
- Active ingredient: Venlafaxine hydrochloride
- Formulation: Extended-release capsules
- Available strengths: 37.5 mg, 75 mg, 150 mg
- Administration: Oral, once daily
- Mechanism: Selective serotonin and norepinephrine reuptake inhibition (SNRI)
- Half-life: Approximately 11 hours (venlafaxine), 13 hours (active metabolite O-desmethylvenlafaxine)
- Bioavailability: 92–100%
Benefits
- Provides dual reuptake inhibition of serotonin and norepinephrine, which may enhance efficacy in treatment-resistant depression
- Extended-release design minimizes peak-trough fluctuations, reducing the incidence of nausea and dizziness
- Demonstrated efficacy in improving mood, energy, interest, and reducing excessive worry and anxiety
- Flexible dosing allows for individualized treatment regimens based on symptom severity and tolerability
- May improve physical symptoms of depression such as fatigue and pain sensitivity
Common use
Effexor XR is indicated for the treatment of major depressive disorder (MDD), generalized anxiety disorder (GAD), social anxiety disorder (SAD), and panic disorder (PD) with or without agoraphobia. It is used in adult patients and may be considered off-label for other conditions under specialist supervision, such as certain chronic pain syndromes or vasomotor symptoms of menopause.
Dosage and direction
Administer orally once daily with food, preferably at the same time each day. Capsules must be swallowed whole; do not crush, chew, or dissolve. For MDD and GAD, initial dose is typically 37.5 mg or 75 mg daily. Dose may be increased in increments of up to 75 mg at intervals of no less than 4 days, as tolerated. Maximum recommended dose is 225 mg per day. For panic disorder, begin at 37.5 mg daily for 7 days before increasing. Dosage adjustments are necessary in hepatic or renal impairment.
Precautions
Monitor for clinical worsening, suicidality, or unusual changes in behavior, especially during initiation and dose adjustments. Use with caution in patients with a history of mania, seizures, hypertension, or angle-closure glaucoma. May increase risk of bleeding, especially when used with NSAIDs, aspirin, or anticoagulants. Discontinuation syndrome may occur; taper gradually when stopping. Not recommended during pregnancy unless potential benefit justifies potential risk to the fetus.
Contraindications
Hypersensitivity to venlafaxine or any component of the formulation. Concomitant use with monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing MAOI therapy due to risk of serotonin syndrome. Avoid use in patients with uncontrolled narrow-angle glaucoma.
Possible side effect
Common: Nausea, headache, drowsiness, dry mouth, dizziness, insomnia, constipation, sweating, nervousness.
Less common: Increased blood pressure, palpitations, blurred vision, weight changes, sexual dysfunction.
Serious (seek medical attention): Serotonin syndrome, abnormal bleeding, hyponatremia, angle-closure glaucoma, manic episode, seizures, suicidal thoughts.
Drug interaction
- MAOIs: Contraindicated; risk of serious, sometimes fatal, reactions
- SSRIs/other serotonergic drugs: Increased risk of serotonin syndrome
- NSAIDs/aspirin/anticoagulants: Increased bleeding risk
- Drugs metabolized by CYP2D6 (e.g., tricyclic antidepressants, antipsychotics): Venlafaxine may increase their levels
- antihypertensives: May diminish effect
Missed dose
Take as soon as remembered unless it is close to the time of the next dose. Do not double the dose to catch up. If a dose is missed, resume the regular dosing schedule the following day.
Overdose
Symptoms may include dizziness, sedation, tachycardia, changes in ECG intervals, seizures, or serotonin syndrome. Cases of fatal overdose have been reported, often in combination with alcohol or other drugs. No specific antidote exists; provide supportive care and symptomatic treatment. Immediate medical attention is required.
Storage
Store at 20–25°C (68–77°F); excursions permitted to 15–30°C (59–86°F). Keep in original container, tightly closed, and protect from moisture and light. Keep out of reach of children and pets.
Disclaimer
This information is for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting, changing, or discontinuing any medication. Individual response to Effexor XR may vary.
Reviews
Clinical studies and patient reports indicate that Effexor XR is effective for many individuals with MDD and anxiety disorders, particularly those who have not responded adequately to SSRIs. Patients often note improvements in mood, motivation, and reduction in anxiety symptoms after several weeks of consistent use. Some report side effects such as initial nausea or sleep disturbances, which often subside with continued use. Adherence to prescribed dosing and regular follow-up with a healthcare provider are strongly associated with better outcomes.